Research ArticleCancer

Repurposing rotavirus vaccines for intratumoral immunotherapy can overcome resistance to immune checkpoint blockade

See allHide authors and affiliations

Science Translational Medicine  23 Oct 2019:
Vol. 11, Issue 515, eaat5025
DOI: 10.1126/scitranslmed.aat5025
PDF Container

Stay Connected to Science Translational Medicine

Navigate This Article